ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon

Indorama Ventures buying plastic feedstock maker in Portugal

Thai chemical company makes another purchase in Europe

BANGKOK -- Thai petrochemical company Indorama Ventures said Thursday it will acquire a Portuguese plant making a feedstock for PET, one of the most commonly used plastics.

The plan is to purchase Artlant PTA, which produces purified terephthalic acid (PTA), for an undisclosed price by the end of the year.

PTA is used to make polyethylene terephthalate (PET), from which plastic bottles are made.

Market conditions for PET have worsened owing to increased output from China. Indorama seeks greater scale through acquisitions to sharpen its cost-competitiveness.

The PTA plant, with an annual output capacity of 700,000 tons, is the second-largest in Europe, trailing only a BP plant. Indorama will also buy an adjacent business that supplies electricity to the plant.

The Thai company is increasing its foothold in Europe. It bought a PET plant in Spain in 2016, and another in the Netherlands this June. Both of these facilities produce PTA as well, but with some of the output being exported, Indorama is boosting its self-sufficiency in the feedstock with the latest acquisition.

You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

Subscribe to get unlimited access to all articles.

Get unlimited access
NAR site on phone, device, tablet

{{sentenceStarter}} {{numberReadArticles}} free article{{numberReadArticles-plural}} this month

Stay ahead with our exclusives on Asia; the most dynamic market in the world.

Benefit from in-depth journalism from trusted experts within Asia itself.

Try 3 months for $9

Offer ends September 30th

Your trial period has expired

You need a subscription to...

See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

See all offers
NAR on print phone, device, and tablet media